SIOP 2025: The Contribution of Armenian Specialists to the Field of Pediatric Oncology
All abstracts submitted by the team of the “Yeolyan” Hematology and Oncology Center have been accepted for presentation at the 57th Annual Congress of the International Society of Paediatric Oncology (SIOP), scheduled to take place from October 20 to 23 this year in Amsterdam.
The topics chosen by our specialists highlight both the unique challenges and the achievements of Armenia in the field of pediatric oncology:
Anahit Zakharyan
“Achieving successful treatment of acute promyelocytic leukemia (APL) in Armenia: A retrospective analysis of treatment outcomes”
Anna Avagyan
“First report of blinatumomab use in a child with ataxia-telangiectasia and B/T mixed phenotype acute leukemia”
Emma Tadevosyan
“Challenges and costs of precision medicine in pediatric oncology: The financial burden of targeted and immunotherapies”
Grigor Vardanyan
“A novel non-transfusion approach to managing acute myeloblastic leukemia”
Henrik Grigoryan
“Critical care challenges in pediatric leukemia: A retrospective analysis from Armenia”
Julieta Hoveyan
“Continuous vs. bolus administration of 5-HT3 antagonists and dexamethasone for control of chemotherapy-induced nausea and vomiting: Results from Armenia’s first pediatric trial”
Mariam Minasyan
“Establishment of a specialized clinic for vascular tumors and malformations in Armenia”
Meri Petrosyan
“Comorbidity of acute lymphoblastic leukemia and West Nile virus”
Ruzanna Papyan
“The neglected middle: Addressing AYA cancer care in low- and middle-income countries — Insights from the SIOP Global Health Network Working Group”
Saten Hovhannisyan
1. “Tubulopathy in osteosarcoma patients treated with OS-99: An observational descriptive comparison “
2. “Chemotherapy administration for osteosarcoma in a pediatric patient with renal failure: A case of dialysis-dependent treatment modifications”
This achievement is yet another testament to our team’s dedicated efforts in advancing pediatric oncology services, promoting scientific progress, and strengthening international collaboration.